CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −54,737 | $32.33 | $1.8M | 5,096,818 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −13,997 | $33.34 | $467K | 5,082,821 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −13,335 | $34.02 | $454K | 5,069,486 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −31,584 | $30.28 | $956K | 969,833 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −28,329 | $31.44 | $891K | 941,504 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −15,324 | $32.33 | $495K | 926,180 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −3,919 | $33.34 | $131K | 922,261 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −3,733 | $34.02 | $127K | 918,528 |
| 2022-12-08 | Mainolfi Nello Chief Executive Officer | Exercise or conversion | +10,000 | $2.08 | $21K | 573,700 |
| 2022-12-08 | Mainolfi Nello Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 18,725 | ||
| 2022-11-03 | Booth Bruce Director | Sale | −75,312 | $30.00 | $2.3M | 5,365,563 |
| 2022-11-03 | Booth Bruce Director | Sale | −21,085 | $30.00 | $633K | 1,001,417 |
| 2022-11-03 | Atlas Venture Fund X, L.P. 10% owner | Sale | −75,312 | $30.00 | $2.3M | 5,365,563 |
| 2022-11-03 | Atlas Venture Fund X, L.P. 10% owner | Sale | −21,085 | $30.00 | $633K | 1,001,417 |
| 2022-11-03 | Sandor Victor Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2022-11-02 | Booth Bruce Director | Sale | −96,581 | $30.02 | $2.9M | 5,440,875 |
| 2022-11-02 | Booth Bruce Director | Sale | −27,038 | $30.02 | $812K | 1,022,502 |
| 2022-11-02 | Atlas Venture Fund X, L.P. 10% owner | Sale | −96,581 | $30.02 | $2.9M | 5,440,875 |
| 2022-11-02 | Atlas Venture Fund X, L.P. 10% owner | Sale | −27,038 | $30.02 | $812K | 1,022,502 |
| 2022-11-01 | Booth Bruce Director | Sale | −56,455 | $30.57 | $1.7M | 5,541,183 |
Page 35 of 41 · 810 trades